Prokaryotics
Brian Burr, JD, is co-founder of the firm B C Burr McCabe Law and has managing Prokaryotics’ legal affairs since its inception. Brian Burr is an experienced legal counsel practicing for 30 years, first as a partner with two prominent global law firms prior to forming his own firm in 2007, B C Burr McCabe Law www.bcbmlaw.com,,specializing in representing biotech, pharmaceutical and technology companies in growth-oriented transactions. He represents companies in a wide variety of complex transactions, including patent licensing; joint ventures; major license, development and commercialization agreements, university transactions and mergers and acquisitions. Prior to forming B C Burr McCabe Law, He was a partner in the Silicon Valley office of Orrick, Herrington & Sutcliffe LLP where he was the head of the technology transactions practice for seven years. Prior to that he was a partner at Pillsbury Madison & Sutro LLP (now Pillsbury Winthrop Shaw Pittman LLP).
This person is not in any teams
This person is not in any offices
Prokaryotics
Prokaryotics is a start-up biotechnology company resulting from licensing several novel antibiotic programs from Merck & Co., Inc. – by a team of former senior scientists at the company including the head of the Antimicrobial Early Discovery Unit, to optimize a number of Merck’s early-stage programs. Prokaryotics has negotiated worldwide rights to develop, manufacture and commercialize pre-clinical assets and programs targeting both Gram-negative and Gram-positive bacteria.